BSE Live
Dec 26, 16:01Prev. Close
424.45
Open Price
422.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:59Prev. Close
422.00
Open Price
420.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
417.30 (4)
| Balance Sheet of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.30 | 23.58 | 23.58 | 23.86 | 24.22 | |
| Total Share Capital | 23.30 | 23.58 | 23.58 | 23.86 | 24.22 | |
| Reserves and Surplus | 598.49 | 494.99 | 409.59 | 363.11 | 326.10 | |
| Total Reserves and Surplus | 598.49 | 494.99 | 409.59 | 363.11 | 326.10 | |
| Total Shareholders Funds | 621.79 | 518.58 | 433.17 | 386.97 | 350.31 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 176.28 | 195.26 | 186.16 | 187.45 | 175.21 | |
| Deferred Tax Liabilities [Net] | 78.59 | 88.48 | 79.86 | 71.45 | 40.41 | |
| Other Long Term Liabilities | 14.43 | 10.45 | 11.44 | 12.42 | 10.27 | |
| Long Term Provisions | 23.62 | 12.80 | 16.87 | 8.66 | 1.42 | |
| Total Non-Current Liabilities | 292.91 | 307.00 | 294.33 | 279.97 | 227.31 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 154.61 | 246.34 | 296.24 | 229.57 | 257.37 | |
| Trade Payables | 316.37 | 228.43 | 239.67 | 170.30 | 164.18 | |
| Other Current Liabilities | 81.36 | 71.15 | 51.94 | 47.63 | 42.24 | |
| Short Term Provisions | 3.65 | 1.43 | 0.89 | 1.68 | 13.28 | |
| Total Current Liabilities | 555.99 | 547.36 | 588.74 | 449.18 | 477.08 | |
| Total Capital And Liabilities | 1,470.70 | 1,372.93 | 1,316.24 | 1,116.12 | 1,054.70 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 610.29 | 582.84 | 559.13 | 536.32 | 455.73 | |
| Intangible Assets | 1.29 | 2.82 | 4.46 | 6.00 | 7.04 | |
| Capital Work-In-Progress | 10.96 | 32.37 | 27.99 | 14.13 | 34.04 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 622.53 | 618.04 | 591.58 | 556.45 | 496.81 | |
| Non-Current Investments | 20.38 | 18.92 | 17.24 | 18.42 | 11.12 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 4.74 | |
| Other Non-Current Assets | 2.42 | 0.97 | 10.77 | 11.76 | 0.00 | |
| Total Non-Current Assets | 645.33 | 637.93 | 619.59 | 586.64 | 512.67 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 307.41 | 227.71 | 254.10 | 188.75 | 167.05 | |
| Trade Receivables | 464.34 | 436.90 | 365.23 | 278.27 | 321.20 | |
| Cash And Cash Equivalents | 3.85 | 4.85 | 3.91 | 4.00 | 4.50 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 18.84 | |
| OtherCurrentAssets | 49.77 | 65.55 | 73.41 | 58.45 | 30.45 | |
| Total Current Assets | 825.36 | 735.00 | 696.65 | 529.48 | 542.03 | |
| Total Assets | 1,470.70 | 1,372.93 | 1,316.24 | 1,116.12 | 1,054.70 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 89.82 | 74.68 | 56.67 | 0.00 | 66.07 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 632.29 | 520.42 | 417.78 | 418.36 | 443.25 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.74 | 3.28 | 2.18 | 3.21 | 2.51 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 16.98 | 15.13 | 8.78 | 8.25 | 11.65 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 510.59 | 502.22 | 380.71 | 391.98 | 358.55 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 17.69 | 17.90 | 17.90 | 18.11 | 18.11 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | 0.46 | |
| Non-Current Investments Unquoted Book Value | 20.38 | 18.92 | 17.24 | 18.42 | 11.03 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y